FDA approves Keytruda and Padcev combo for bladder cancer treatment

Go back to FDA approves Keytruda and Padcev combo for bladder cancer treatment
Merck & Co. (NYSE: MRK) Delayed: 148.75 +0.45 (0.30%)
Previous Close $148.30    52 Week High $65.46 
Open $147.11    52 Week Low $47.97 
Day High $149.44    P/E 101.19 
Day Low $147.11    EPS $1.47 
Volume 3,028,793       

Pfizer Inc. (NYSE: PFE) Delayed: 29.81 -0.3 (1%)
Previous Close $30.11    52 Week High $37.39 
Open $30.00    52 Week Low $28.25 
Day High $30.09    P/E 18.07 
Day Low $29.72    EPS $1.65 
Volume 7,308,662